![]() |
|
|
Vol. 292, Issue 2, 497-504, February 2000
Inhibits
-Aminobutyric Acid Type A
(GABAA) Receptor Current in Cultured Hippocampal
Neurons
Departments of Anesthesiology (S.W., J.Y.) and
Pharmacology/Physiology (Q.C., S.M., J.Y.), University of Rochester
Medical Center, Rochester, New York.
Interleukin-1
(IL-1
), a polypeptide immune mediator, is induced
within the central nervous system in response to a variety of
pathological stimuli, including systemic infection, hypoxia, brain
trauma, and seizure. IL-1
action on the
-aminobutyric acid type A
(GABAA) inhibitory neurotransmitter receptor was
investigated in whole cell patch-clamped cultured hippocampal neurons.
Application of IL-1
at concentrations encountered in
pathophysiological conditions (1-10 ng/ml; 59-590 pM) irreversibly
decreased the peak magnitude of current elicited by 30 µM GABA.
Current inhibition was IL-1
concentration- and time-dependent and
was prevented by a specific IL-1
type I receptor antagonist. No
significant changes in current kinetics or reversal potential were
observed. The IL-1
depression of GABA current was inhibited by high
concentrations of nonspecific kinase inhibitors staurosporine (500 nM)
and 1-(5-isoquinolinyl-sulfonyl)-2-methylpiperazine (H-7; 50 µM), but not by a protein kinase C selective inhibitor calphostin C
(5 µM). We conclude that IL-1
inhibits GABAA receptor function in hippocampal neurons by the involvement of an
unidentified kinase. This blockade of the GABAA inhibitory
neurotransmitter receptor may underlie the central nervous system
hyperexcitability seen in many pathophysiological conditions.
This article has been cited by other articles:
![]() |
K. Riazi, M. A. Galic, J. B. Kuzmiski, W. Ho, K. A. Sharkey, and Q. J. Pittman Microglial activation and TNF{alpha} production mediate altered CNS excitability following peripheral inflammation PNAS, November 4, 2008; 105(44): 17151 - 17156. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Galic, K. Riazi, J. G. Heida, A. Mouihate, N. M. Fournier, S. J. Spencer, L. E. Kalynchuk, G. C. Teskey, and Q. J. Pittman Postnatal Inflammation Increases Seizure Susceptibility in Adult Rats J. Neurosci., July 2, 2008; 28(27): 6904 - 6913. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Serantes, F. Arnalich, M. Figueroa, M. Salinas, E. Andres-Mateos, R. Codoceo, J. Renart, C. Matute, C. Cavada, A. Cuadrado, et al. Interleukin-1beta Enhances GABAA Receptor Cell-surface Expression by a Phosphatidylinositol 3-Kinase/Akt Pathway: RELEVANCE TO SEPSIS-ASSOCIATED ENCEPHALOPATHY J. Biol. Chem., May 26, 2006; 281(21): 14632 - 14643. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Donnelly, C. E. Loscher, M. A. Lynch, and K. H. G. Mills Whole-Cell but Not Acellular Pertussis Vaccines Induce Convulsive Activity in Mice: Evidence of a Role for Toxin-Induced Interleukin-1{beta} in a New Murine Model for Analysis of Neuronal Side Effects of Vaccination Infect. Immun., July 1, 2001; 69(7): 4217 - 4223. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vezzani, D. Moneta, M. Conti, C. Richichi, T. Ravizza, A. De Luigi, M. G. De Simoni, G. Sperk, S. Andell-Jonsson, J. Lundkvist, et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice PNAS, September 29, 2000; (2000) 190206797. [Abstract] [Full Text] |
||||
![]() |
A. Vezzani, D. Moneta, M. Conti, C. Richichi, T. Ravizza, A. De Luigi, M. G. De Simoni, G. Sperk, S. Andell-Jonsson, J. Lundkvist, et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice PNAS, October 10, 2000; 97(21): 11534 - 11539. [Abstract] [Full Text] [PDF] |
||||